This study further reveals that RBBP4 can regulate cisplatin sensitivity by modulating cyclin D1 expression, consistent with previous findings that RBBP4 knockdown inhibits epithelial-mesenchymal transition in cervical cancer cells. The gene discussed is CCND1; the disease is cervical carcinoma.